FindTrial
Sign In

Intervention 1: The intervention group: The intervention group will receive high-concentration desmopressin spray nasally Octostim® (concentration of 150 micrograms per milliliter) (Ferring GmbH, Germ

2 trials

Sponsors

Shiraz University of Medical Sciences

Conditions

Condition 1: Bleeding. Condition 2: Kidney biopsy. Postprocedural hemorrhage and hematoma of skin and subcutaneous tissue following other procedureCondition 1: Bleeding. Condition 2: Kidney biopsy. Condition 3: Acute kidney failure. Postprocedural hemorrhage and hematoma of skin and subcutaneous tissue following other procedure Acute kidney failure, unspecified

Phase 3

Evaluation of the effect of intranasal desmopressin spray on the complications of kidney biopsy in renal failure
Active, not recruitingIRCT20201019049075N1
Shiraz University of Medical SciencesCondition 1: Bleeding. Condition 2: Kidney biopsy. Condition 3: Acute kidney failure. Postprocedural hemorrhage and hematoma of skin and subcutaneous tissue following other procedure Acute kidney failure, unspecified
Start: 2019-12-22Target: 60Updated: 2021-08-30
Evaluation of the effect of intranasal desmopressin spray on complications of kidney biopsy
Active, not recruitingIRCT20201019049075N2
Shiraz University of Medical SciencesCondition 1: Bleeding. Condition 2: Kidney biopsy. Postprocedural hemorrhage and hematoma of skin and subcutaneous tissue following other procedure
Start: 2019-04-04Target: 60Updated: 2021-11-01